Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Loading metrics Open Access Peer-reviewed Research Article Nina Seylanova, Siobhan Crichton, Jing Zhang, Richard Fisher, Marlies Ostermann Nina Seylanova, Siobhan Crichton, Jing Zhang, Richard Fisher, Marlies Ostermann Published: May 21, 2020 https://doi.org/10.1371/journal.pone.0232370 Figures Abstract Background In critically ill patients, acute kidney injury (AKI) is common and associated with short- and long-term complications.
Growth factor therapy is to administrate pro-epidermal growth factors to promote wound healing. These growth factors are bioactive molecules secreted by the body whose function is to stimulate the growth and propagation of cells involved in skin wound healing and inflammation. The use of extra-growth factor increases the number of wound-healing cells, causing faster wound healing.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
